Search results
Jun 20, 2024 · Jazz Pharmaceuticals develops and commercializes medicines for rare and serious diseases, such as sleep disorders, cancer, and neurology. Learn about their science stories, perspectives, news, and events.
- About
At Jazz Pharmaceuticals plc (NASDAQ: JAZZ), our purpose is...
- Medicines
Jazz Pharmaceuticals has a diverse portfolio of meaningful...
- Science
At Jazz, we use patient-centric innovation to drive our...
- Our Purpose
Jazz Pharmaceuticals recognizes that many patients today...
- News
Jazz Pharmaceuticals plc. Send Email Ireland: +353 1 637...
- Investors
Jazz Pharmaceuticals Announces Successful Completion of Term...
- Careers
Careers at Jazz Pharmaceuticals Shared Values. Shared...
- Drug Safety
Sativex is marketed in the UK by Jazz. If you are a medical...
- About
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States.
Find the latest Jazz Pharmaceuticals plc (JAZZ) stock quote, history, news and other vital information to help you with your stock trading and investing.
Feb 28, 2024 · Jazz Pharmaceuticals reported $3.8 billion in total revenue and $1 billion in oncology revenue in 2023, driven by Xywav, Epidiolex and Rylaze. The company expects double-digit growth in 2024, with multiple late-stage pipeline catalysts in biliary tract cancer, glioblastoma, essential tremor and more.
Learn about Jazz Pharmaceuticals, a company that develops life-changing medicines for serious diseases with limited or no options. See their locations, employees, specialties, updates and more on LinkedIn.
Jun 28, 2022 · Jazz Pharmaceuticals announced the results of a Phase 3 trial of nabiximols oromucosal spray, a cannabis-derived medication, for spasticity in multiple sclerosis. The trial did not meet the primary endpoint, but the company plans to present the data and continue with two other ongoing trials.
Jul 17, 2024 · Get the latest stock price, earnings, analyst ratings, and news for Jazz Pharmaceuticals PLC (JAZZ), a biopharmaceutical company focused on neurology and psychiatry. See how JAZZ compares to its competitors and market performance.